Pax-8 is a reliable marker in making the diagnosis in advanced stage epithelial ovarian carcinoma and primary peritoneal carcinoma for neoadjuvant chemotherapy on cell block and biopsy specimens

Histopathology

Volumn 60, Issue 6, 2012, Pages 1019-1020

  Mhawech Fauceglia, Paulette ^a   Wang, Dan ^a   Menesses, Teodulo ^a   Chandavarkar, Uma ^b   Ough, Faith ^a   Lin, Yvonne ^b   Liu, Song ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CALRETININ; CYTOKERATIN 20; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; PROGESTERONE RECEPTOR; PROSTAGLANDIN E RECEPTOR 4; THYROGLOBULIN; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR PAX8; UROPLAKIN; WT1 PROTEIN;

ASCITES FLUID; ASPIRATION BIOPSY; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CARCINOSARCOMA; CONTROLLED STUDY; EPITHELIAL OVARY CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; OVARY CARCINOMA; PERITONEUM CANCER; PLEURA FLUID; PRIMARY PERITONEAL CARCINOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SUPRACLAVICULAR LYMPH NODE;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOADJUVANT THERAPY; OVARIAN NEOPLASMS; PAIRED BOX TRANSCRIPTION FACTORS; PERITONEAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862784921     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04172.x     Document Type: Letter

References (6)

1. Vergote I, Trope CG, Amant F et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N. Engl. J. Med. 2010; 363; 943-953.
2. McCluggage WG, Young RH. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumours. Semin. Diagn. Pathol. 2005; 22; 3-32.
3. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod. Pathol. 2000; 13; 962-972.
4. Laury AR, Hornick JL, Perets R et al. PAX8 reliably distinguishes ovarian serous tumours from malignant mesothelioma. Am. J. Surg. Pathol. 2010; 34; 627-635.
5. Nonaka D, Chiriboga L, Soslow RA. Expression of Pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am. J. Surg. Pathol. 2008; 32; 1566-1571.
6. Laury AR, Peters R, Piao H et al. A comprehensive analysis of PAX8 expression in human epithelial tumours. Am. J. Surg. Pathol. 2011; 35; 816-826.